Gene · 94
Papers4,014
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 4,014
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hybrid Feature Selection-Based Machine Learning and Deep Learning Framework for Biomarker Prediction From RNA-seq Data During Dengue Fever to Severe Dengue Progression. | Evol Bioinform Online | 2026 | 42137783 | PubTator, text mining | PubMed |
| The preponderance of genetic variations in paediatric pulmonary hypertension. | Respir Med Res | 2026 | 42114419 | PubTator, text mining | PubMed |
| Pulmonary Hypertension Following the Use of Trastuzumab Biosimilars. | Case Rep Pulmonol | 2026 | 42089011 | PubTator, text mining | PubMed |
| Targeted Sequencing of Human Aorta Tissue Reveals Undiagnosed Heritable Thoracic Aortic Disease. | Interdiscip Cardiovasc Thorac Surg | 2026 | 41999216 | PubTator, text mining | PubMed |
| Molecular Characterization of Biphasic Follicular Dendritic Cell Sarcoma. | Appl Immunohistochem Mol Morphol | 2026 | 41943444 | PubTator, text mining | PubMed |
| Mitotic error correction and the spindle assembly checkpoint: a tension-filled relationship. | Cell Cycle | 2026 | 41930946 | PubTator, text mining | PubMed |
| Genotype-phenotype correlations and protein domain-level predictors of cerebrovascular malformations in hereditary hemorrhagic telangiectasia. | J Neurol | 2026 | 41915210 | PubTator, text mining | PubMed |
| Generation of ALK1 p.Gly48Glu mutant LUMCi029-A-3 for modeling Hereditary hemorrhagic telangiectasia type 2. | Stem Cell Res | 2026 | 41905104 | PubTator, text mining | PubMed |
| BMPR2 Dosage Gates BMP9/10 Signaling Output in Pulmonary Artery Endothelium. | Cells | 2026 | 41892283 | PubTator, text mining | PubMed |
| A case of hereditary hemorrhagic telangiectasia with ACVRL1 gene variant. | Dermatol Reports | 2026 | 41891344 | PubTator, text mining | PubMed |
| Future Prospects of Imatinib in Advanced Pulmonary Hypertension Management. | IUBMB Life | 2026 | 41885124 | PubTator, text mining | PubMed |
| A single-cell and spatial transcriptomic atlas of human tuberculous constrictive pericardium. | EBioMedicine | 2026 | 41875497 | PubTator, text mining | PubMed |
| Clinical Manifestations of Primary CNS T-Cell Lymphoma: A Retrospective Study of Histopathologic, Molecular, and Neuroimaging Features. | Neurology | 2026 | 41843861 | PubTator, text mining | PubMed |
| Exosomal Rspondin3 serves as a master regulator of immunometabolic repair in sepsis: synergistic activation of macrophage M2 polarization and endothelial BMP10 signaling. | Int Immunopharmacol | 2026 | 41839470 | PubTator, text mining | PubMed |
| Molecular dynamics simulations refine the pathogenicity of ACVRL1 kinase domain variants by quantifying impacts on ATP binding in pulmonary arterial hypertension. | J Struct Biol | 2026 | 41839337 | PubTator, text mining | PubMed |
| Laryngeal ALK Positive Histiocytosis: Potential Mimic of Inflammatory Myofibroblastic Tumor-Case Report and Literature Review. | Head Neck Pathol | 2026 | 41824143 | PubTator, text mining | PubMed |
| Integrative prenatal imaging and genomic testing in fetal congenital heart defects: Insights from a 30-year retrospective study. | Taiwan J Obstet Gynecol | 2026 | 41813389 | PubTator, text mining | PubMed |
| Flow-induced Klf4-Akt signaling links EC cycling to mural cell defects in arterial-venous malformations. | Theranostics | 2026 | 41799188 | PubTator, text mining | PubMed |
| BMPR2 Splice-Site Variant in a Patient With Pulmonary Arteriovenous Malformation and Delayed-Onset Pulmonary Arterial Hypertension: A Case Report and Mechanistic Phenocopy Hypothesis. | Am J Med Genet A | 2026 | 41795626 | PubTator, text mining | PubMed |
| The Effect of Bevacizumab Therapy on Reducing Erythrocyte Transfusion Requirements and Preventing Iron Deficiency in Patients With Hereditary Hemorrhagic Telangiectasia. | Cureus | 2026 | 41769502 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/94/papers?page=2